AGUAS DA CURIA 주식 가격. CUR - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

프리미엄

가격

1.17

매수가

1.17

매도가

1.17

거래량

0.00

0.00 일간 변동폭 0.00

1.17 52주 범위 1.17

전일 종가

1.17

개장가

최근 거래 시간

마지막 거래 시간

평균 볼륨(3m)

0.00

재정 규모

VWAP

Neuralstem Completes $5.25 Million Financing

Received NYSE AMEX Notice of Compliance ROCKVILLE, Md., Feb. 18 /PRNewswire-FirstCall/ -- Neuralstem, Inc. (NYSE AMEX: CUR) announced today that it has raised a total of $5,228,000 since the...

Neuralstem Announces First Patient Treated in ALS Stem Cell Trial

ROCKVILLE, Md., Jan. 21 /PRNewswire-FirstCall/ -- Neuralstem, Inc. (NYSE Amex: CUR) announced that the first ALS patient was treated with its spinal cord stem cells yesterday at the Emory ALS...

Neuralstem Receives Approval To Commence First ALS Stem Cell Trial at Emory ALS Center

ROCKVILLE, Md., Dec. 18 /PRNewswire-FirstCall/ -- Neuralstem, Inc. (NYSE Amex: CUR) today announced that its Phase I trial to treat Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's disease...

Neuralstem, Inc. Reports Third Quarter Financial Results and Provides Business Update

ROCKVILLE, Md., Nov. 17 /PRNewswire-FirstCall/ -- Neuralstem, Inc. (NYSE Amex: CUR) today provided a financial and business update for the third quarter ended September 30, 2009. (Logo:...

Neuralstem Receives FDA Approval to Commence First ALS Stem Cell Trial

ROCKVILLE, Md., Sept. 21 /PRNewswire-FirstCall/ -- Neuralstem, Inc. (NYSE Amex: CUR) today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug...

Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Neuralstem, Inc.

NEW YORK, April 6 /PRNewswire/ -- Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview(R) (EIO(R)) on Neuralstem, Inc. (NYSE Amex: CUR). The...

Neuralstem's Human Stem Cells Integrate into Nervous System of Rats with Animal Model of ALS

Make Synaptic Contact with Host Motor Neurons ROCKVILLE, Md., March 9 /PRNewswire-FirstCall/ -- Transplanted human neural stem cells (hNSCs) developed by Neuralstem, Inc. (NYSE Alternext US:...

Neuralstem's ALS Trial on Clinical Hold

ROCKVILLE, Md., Feb. 20 /PRNewswire-FirstCall/ -- Neuralstem, Inc. (NYSE Alternext US: CUR) announced today its spinal cord stem cell trial to treat ALS is on clinical hold and that the Federal...

Senator James Sasser, Former Ambassador to China, Joins Neuralstem Advisory Board

ROCKVILLE, Md., Feb. 12 /PRNewswire-FirstCall/ -- Neuralstem, Inc. (NYSE Alternext US: CUR) announced today that James Sasser, former Senator (D-Tennessee) and former Ambassador to the People's...

Neuralstem to Present at the 11th Annual BIO CEO & Investor Conference

ROCKVILLE, Md., Feb. 2 /PRNewswire-FirstCall/ -- Neuralstem, Inc. (NYSE Alternext US: CUR) announced today that Richard Garr, CEO and President, will present at the 11th Annual BIO CEO...

기간	시가	고가	저가
1	1.17	1.17	1.17	DE
4	1.17	1.17	1.17	DE
12	1.17	1.17	1.17	DE
26	1.17	1.17	1.17	DE
52	1.17	1.17	1.17	DE
156	1.17	1.17	1.17	DE
260	1.17	1.17	1.17	DE

가장 활성
% 상승자
% 패자

기호	가격	볼륨
ABEOABEO SA	9.78 € (0.00%)	0
ABCAABC Arbitrage	4.78 € (0.00%)	0
ABAb Science	0.79 € (0.00%)	0
AALBAalberts NV	34.46 € (0.00%)	0
AAAAlan Allman Associates	4.00 € (0.00%)	0
ABEOABEO SA	9.78 € (0.00%)	0
ABCAABC Arbitrage	4.78 € (0.00%)	0
ABAb Science	0.79 € (0.00%)	0
AALBAalberts NV	34.46 € (0.00%)	0
AAAAlan Allman Associates	4.00 € (0.00%)	0
ABEOABEO SA	9.78 € (0.00%)	0
ABCAABC Arbitrage	4.78 € (0.00%)	0
ABAb Science	0.79 € (0.00%)	0
AALBAalberts NV	34.46 € (0.00%)	0
AAAAlan Allman Associates	4.00 € (0.00%)	0